Stay updated on IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page revision label updated from v3.2.0 to v3.3.1 with no visible changes to content or functionality.SummaryDifference0.1%

- Check29 days agoChange DetectedFunding status notice/banner was removed from the page, eliminating an administrative operating-status message; this does not affect the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedNo significant additions or deletions were observed on the page; the content appears unchanged.SummaryDifference0.4%

- Check71 days agoChange DetectedIntroducing a major status notice about government funding and NIH Clinical Center operations (including links to official sources) and updating the page version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check79 days agoChange DetectedUpdated the page to reflect a newer software version (from v3.0.2 to v3.1.0); the old version tag was removed and a new one added. This is a metadata/versioning update rather than substantive content change.SummaryDifference0.1%

Stay in the know with updates to IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.